Paxman AB (publ) Stock: price and insider trades · Sweden
1 insider bought €13k of shares over the last 90 days, the latest by Per-Anders Johansson, filed 26 Aug 2026.
Paxman AB (publ): what insiders have been doing
Paxman AB (publ) belongs to the Health Care sector. Filings by its managers are published through Finansinspektionen. In the past year (29 October 2025 to 29 October 2026), 14 filings came from 6 insiders.
On the market, 4 insiders bought (11 purchases totalling €374k) while 1 insider sold (1 sale totalling €276k). On balance, insiders were net buyers of €98k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €276k, the purchase published on 25 May 2026 by Glenn Paxman is the largest of the period (0.30% of market cap). The buyers include 4 board members.
In the case of 7 purchases, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The clock since the last published purchase (26 August 2026) now reads 74 days. Typically, a trade is published a median of 1 day after it takes place. The regulation allows three business days to notify a trade (MAR article 19).
For context, the typical company on the same exchange (median of 1,033 companies) published 9 filings over the same period, against 14 filings here. The full history, which starts in 2017, counts 47 purchases against 53 sales.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- +16.5%Entry SEK 57.10 · Close 21 Oct 2026 SEK 66.50
- +30.1%Entry SEK 51.10 · Close 21 Oct 2026 SEK 66.50
- +28.9%Entry SEK 51.60 · Close 21 Oct 2026 SEK 66.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Paxman AB (publ) Strong Buy (bullish), based on 2 analysts. Average price target: SEK 96.00.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 2,500 shares@ SEK 58.400.010% mcap9.7% of flowAktieISIN SE0009806284FI:csv-7a5346c3fa07bf727c09Canonical exit: 24 Nov 2026 (T+90)
- 2,000 shares@ SEK 49.000.0095% mcap6.5% of flowAktieISIN SE0009806284FI:csv-4c7b74818975a5239e50Canonical exit: 23 Sept 2026 (T+90)
- 1,000 shares@ SEK 50.400.0049% mcap3.4% of flowAktieISIN SE0009806284FI:csv-a621526c952869f67fb1Canonical exit: 21 Sept 2026 (T+90)
- 7,000 shares@ SEK 50.000.034% mcap23.3% of flowAktieISIN SE0009806284FI:csv-840897785263bbefe04bCanonical exit: 21 Sept 2026 (T+90)
- 1,000 shares@ SEK 51.300.0051% mcap3.5% of flowAktieISIN SE0009806284FI:A003Z192-1Canonical exit: 24 Aug 2026 (T+90)
- 60,000 shares@ SEK 50.000.30% mcap2.4% of flowAktieISIN SE0009806284FI:A003Z120-1Canonical exit: 23 Aug 2026 (T+90)
- 60,000 shares@ SEK 50.000.30% mcap75.3% of flowAktieISIN SE0009806284FI:A003Z119-1
- 537 shares@ SEK 51.600.0027% mcap89.5% of flowAktieISIN SE0009806284FI:csv-d5677b76a1dc4b12ae82Canonical exit: 20 Aug 2026 (T+90)
- 63 shares@ SEK 51.7010.5% of flowAktieISIN SE0009806284FI:A003Z028-1Canonical exit: 20 Aug 2026 (T+90)
- 3,000 shares@ SEK 50.000.015% mcap10.2% of flowAktieISIN SE0009806284FI:A003Y991-1Canonical exit: 19 Aug 2026 (T+90)
- 1,120 shares@ SEK 48.800.0054% mcap3.7% of flowAktieISIN SE0009806284FI:A003X512-1Canonical exit: 30 Jun 2026 (T+90)
- 20,000 shares0AktieISIN SE0009806284FI:csv-fad04bc8ccd083b97a6b
- 20,000 shares0AktieISIN SE0009806284FI:csv-0138db980f09eec02cf4
- 2,500 shares@ SEK 59.000.015% mcap10.0% of flowAktieISIN SE0009806284FI:A003T691-1Canonical exit: 12 Feb 2026 (T+90)
- 14,880 shares@ SEK 67.205.3% of flowAktieISIN SE0009806284FI:csv-b707c25fb067bceefef8Canonical exit: 23 Dec 2025 (T+90)
- 2,080 shares@ SEK 67.200.014% mcap100.0% of flowAktieISIN SE0009806284FI:A003S569-1Canonical exit: 22 Dec 2025 (T+90)
- 14,880 shares@ SEK 67.200.098% mcap24.7% of flowAktieISIN SE0009806284FI:A003S578-1Canonical exit: 22 Dec 2025 (T+90)
- 1,850,000 shares@ SEK 67.2012.13% mcap97.4% of flowAktieISIN SE0009806284FI:A003S584-1
- 15,122 shares@ SEK 74.40TeckningsoptionISIN SE0009806284FI:csv-2e1dd0032cff1e957f94
- 15,122 shares0TeckningsoptionISIN SE0009806284FI:A003S236-2
- 18,788 shares0TeckningsoptionISIN SE0009806284FI:A003S232-1
- 17,576 shares0TeckningsoptionISIN SE0009806284FI:A003S225-1
- 10,000 shares0TeckningsoptionISIN SE0009806284FI:A003S233-1
- 17,576 shares0TeckningsoptionISIN SE0009806284FI:csv-266bcebc7cfb96c8575e
- 12,728 shares0TeckningsoptionISIN SE0009806284FI:csv-9f5682ba606d0e3fdf68
25 of 111 declarations
About Paxman AB (publ)
Paxman AB (publ) is a Swedish company focused on developing solutions for managing the side effects of chemotherapy. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
